ArticleStem cell reports2024

Targeting glioblastoma with a brain-penetrant drug that impairs brain tumor stem cells via NLE1-Notch1 complex.

Audrey Burban et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.